Cargando…
Histone lysine methyltransferase-related neurodevelopmental disorders: current knowledge and saRNA future therapies
Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that c...
Autores principales: | Roth, Charlotte, Kilpinen, Helena, Kurian, Manju A., Barral, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009263/ https://www.ncbi.nlm.nih.gov/pubmed/36923252 http://dx.doi.org/10.3389/fcell.2023.1090046 |
Ejemplares similares
-
Targets of histone H3 lysine 9 methyltransferases
por: Levinsky, Aidan J., et al.
Publicado: (2022) -
Structural Paradigms in the Recognition of the Nucleosome Core Particle by Histone Lysine Methyltransferases
por: Janna, Ashley, et al.
Publicado: (2020) -
Histone Lysine Methyltransferase SETD2 Regulates Coronary Vascular Development in Embryonic Mouse Hearts
por: Chen, Fengling, et al.
Publicado: (2021) -
Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
por: Reebye, Vikash, et al.
Publicado: (2018) -
The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta
por: Keikha, Reza, et al.
Publicado: (2021)